Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

PURPOSE: Currently, no genomic signature exists to distinguish men most likely to progress on adjuvant androgen deprivation therapy (ADT) after radical prostatectomy for high-risk prostate cancer. Here we develop and validate a gene expression signature to predict response to postoperative ADT. EXPE...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Clin Cancer Res
Κύριοι συγγραφείς: Karnes, R. Jeffrey, Sharma, Vidit, Choeurng, Voleak, Ashab, Hussam Al-Deen, Erho, Nicholas, Alshalalfa, Mohammed, Trock, Bruce, Ross, Ashley, Yousefi, Kasra, Tsai, Harrison, Zhao, Shuang G., Tosoian, Jeffrey J., Haddad, Zaid, Takhar, Mandeep, Chang, S. Laura, Spratt, Daniel E., Abdollah, Firas, Jenkins, Robert B., Klein, Eric A., Nguyen, Paul L., Dicker, Adam P., Den, Robert B., Davicioni, Elai, Feng, Felix Y., Lotan, Tamara L., Schaeffer, Edward M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2018
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512950/
https://ncbi.nlm.nih.gov/pubmed/29760221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2745
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια